// App-Quantinova.ai

e18066 : Real-world use of epoetin zeta compared to guidelines for chemotherapy-induced anemia.

Researchers

Presenter

  • Florian Scotte

Principal Investigators

  • Kamel Laribi

  • Christian Gisselbrecht

  • Isabelle Laure Ray-Coquard

  • Emna Kasdaghli

  • Dominique Spaeth

Medical Centers

  • Hopital European Georges Pompidou, Paris, France

  • Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France

  • Hospital Saint Antoine, Paris, France

  • Centre Leon Berard, Lyon, France

  • Hospira France, Meudon La foret, France

  • ORACLE, Centre d'Oncologie de Gentilly, Gentilly, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hematological malignancies

  • Solid malignancies

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Epo-zeta

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • NCT02158169

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved